Here, CPT highly activates AMPK in cancer cells and significantly inhibits mTORC1 through AMPK-TSC2 axis, indicating that CPT is a natural potent AMPK activator and suitable for clinical cancer therapy. The gene discussed is TSC2; the disease is cancer.